We therefore propose a cfDNA–PRR–KC axis that may underlie an immune–metabolic subtype of NAFLD, providing a possible explanation for disease heterogeneity and expanding the functional scope of DNASE1L3 beyond classical immune contexts.40 Here, CALCA is linked to metabolic dysfunction-associated steatotic liver disease.